Ketamine Therapy in Wisconsin

Ketamine therapy in Wisconsin is governed by a combination of federal regulations and state-level medical practice laws. At the federal level, ketamine is classified as a Schedule III controlled substance under the Controlled Substances Act, meaning that any provider administering or prescribing it must hold a valid DEA registration. Wisconsin clinics operating within this framework are required to maintain strict documentation, inventory controls, and patient records in compliance with both DEA requirements and the Wisconsin Controlled Substances Act.

In Wisconsin, the authority to administer ketamine infusions rests with licensed medical professionals operating under the oversight of the Wisconsin Medical Examining Board, which falls under the Wisconsin Department of Safety and Professional Services (DSPS). Physicians (MD or DO), advanced practice registered nurses (APRNs), and certified registered nurse anesthetists (CRNAs) may be involved in ketamine administration, provided they are practicing within their defined scope of licensure. Clinics must ensure that a qualified provider is present during infusion sessions, as ketamine carries dissociative and anesthetic properties that require clinical monitoring.

While Wisconsin does not have ketamine-specific legislation, providers are bound by general standards of care and professional conduct established by their respective licensing boards. Key regulatory considerations for Wisconsin ketamine clinics include:

• Maintaining a valid DEA Schedule III controlled substance registration
• Complying with Wisconsin's prescription drug monitoring program, PDMP (Prescription Drug Monitoring Program), administered by the Wisconsin Department of Health Services
• Adhering to informed consent requirements and thorough pre-treatment psychiatric and medical evaluations
• Following proper storage, handling, and disposal protocols for controlled substances
• Ensuring facility compliance with applicable state health and safety regulations

Patients seeking ketamine therapy in Wisconsin are encouraged to verify that their chosen clinic employs board-certified physicians or appropriately licensed providers and follows evidence-based protocols for treatment. Because the regulatory landscape around ketamine therapy continues to evolve nationally, prospective patients and providers alike should consult the Wisconsin DSPS and the Wisconsin Department of Health Services for the most current guidance. Clinics affiliated with professional organizations such as the American Society of Ketamine Physicians, Psychotherapists and Practitioners (ASKP3) may offer an additional layer of assurance regarding ethical and clinical standards.